Mickaël Ohanna

发表

Atrophy of S6K1−/− skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control

N. Sonenberg, P. Kelly, E. Petroulakis, 2005, Nature Cell Biology.

S6 kinase inactivation impairs growth and translational target phosphorylation in muscle cells maintaining proper regulation of protein turnover.

M. Sandri, M. Pende, V. Mieulet, 2007, American journal of physiology. Cell physiology.

Secretome from senescent melanoma engages the STAT3 pathway to favor reprogramming of naive melanoma towards a tumor-initiating cell phenotype

V. Bonazzi, K. Bille, P. Bahadoran, 2013, Oncotarget.

Control of Metabolism and Growth Through Insulin-Like Peptides in Drosophila

R. Delanoue, P. Léopold, C. Géminard, 2006, Diabetes.

Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasis

V. Prod’homme, J. Borg, A. Mallavialle, 2015, Nature Communications.

Growth hormone promotes skeletal muscle cell fusion independent of insulin-like growth factor 1 up-regulation.

P. Kelly, M. Pende, J. Kopchick, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Fitting MITF regulation of PDE4D3 into the skin pigmentation puzzle

C. Bertolotto, R. Ballotti, Mickaël Ohanna, 2011, Pigment cell & melanoma research.

Persistent activation of the Fyn/ERK kinase signaling axis mediates imatinib resistance in chronic myelogenous leukemia cells through upregulation of intracellular SPARC.

G. Robert, P. Auberger, M. Deckert, 2010, Cancer research.

E2F1 inhibition mediates cell death of metastatic melanoma

P. Abbe, C. Bertolotto, R. Ballotti, 2018, Cell Death & Disease.

Emerging Role of Deubiquitinating Enzymes (DUBs) in Melanoma Pathogenesis

M. Deckert, Mickaël Ohanna, Pierric Biber, 2022, Cancers.

The Stress-Responsive microRNA-34a Alters Insulin Signaling and Actions in Adipocytes through Induction of the Tyrosine Phosphatase PTP1B

J. Tanti, M. Cormont, J. Jager, 2022, Cells.

Fifteen‐year quest for microphthalmia‐associated transcription factor target genes

C. Bertolotto, R. Ballotti, Y. Cheli, 2010, Pigment cell & melanoma research.

Advances in melanoma senescence and potential clinical application

C. Bertolotto, R. Ballotti, Sandy Giuliano, 2011, Pigment cell & melanoma research.

Senescent cells develop a PARP-1 and nuclear factor-{kappa}B-associated secretome (PNAS).

K. Bille, C. Bertolotto, R. Ballotti, 2011, Genes & Development.

Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas.

Laurent Beuret, K. Bille, P. Bahadoran, 2010, Cancer research.

Aurora B Is Regulated by the Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase (MAPK/ERK) Signaling Pathway and Is a Valuable Potential Target in Melanoma Cells*

K. Bille, P. Bahadoran, C. Bertolotto, 2012, The Journal of Biological Chemistry.

SIRT1 promotes proliferation and inhibits the senescence-like phenotype in human melanoma cells

K. Bille, P. Bahadoran, C. Bertolotto, 2014, Oncotarget.

Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner

P. Abbe, P. Bahadoran, C. Bertolotto, 2013, Molecular Cancer Therapeutics.

Blockade of the pro‐fibrotic reaction mediated by the miR‐143/‐145 cluster enhances the responses to targeted therapy in melanoma

D. Gilot, J. Marine, M. Deckert, 2022, EMBO molecular medicine.

Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix‐mediated tumor cell adaptation and tolerance to BRAF‐targeted therapy in melanoma

V. Prod’homme, A. Mallavialle, M. Deckert, 2021, EMBO molecular medicine.

Targeting the Proteasome-Associated Deubiquitinating Enzyme USP14 Impairs Melanoma Cell Survival and Overcomes Resistance to MAPK-Targeting Therapies

P. Auberger, A. Mallavialle, M. Deckert, 2018, Molecular Cancer Therapeutics.

Rapid decay of engulfed extracellular miRNA by XRN1 exonuclease promotes transient epithelial-mesenchymal transition

B. Mari, C. Staedel, P. Brest, 2018, Nucleic acids research.

Rapid decay of engulfed extracellular miRNA by XRN1 exonuclease promotes transient epithelial-mesenchymal transition

B. Mari, C. Staedel, P. Brest, 2016, Nucleic acids research.

Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression

K. Bille, C. Bertolotto, F. Luciani, 2017, Journal of the National Cancer Institute.

Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype

K. Bille, C. Bertolotto, R. Ballotti, 2018, Genes & development.

BRCA1 is a new MITF target gene

Laurent Beuret, C. Bertolotto, R. Ballotti, 2011, Pigment Cell & Melanoma Research.

E2F1 inhibition mediates cell death of metastatic melanoma

P. Abbe, C. Bertolotto, R. Ballotti, 2018, Cell Death & Disease.

Resistance to lysosomotropic drugs used to treat kidney and breast cancers involves autophagy and inflammation and converges in inducing CXCL5

N. Rioux-Leclercq, G. Pagès, V. Imbert, 2019, Theranostics.

Rapid decay of engulfed extracellular miRNA by XRN1 exonuclease promotes transient epithelial-mesenchymal transition

B. Mari, C. Staedel, P. Brest, 2016, Nucleic acids research.

Aurora B Is Regulated by the Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase (MAPK/ERK) Signaling Pathway and Is a Valuable Potential Target in Melanoma Cells*

K. Bille, P. Bahadoran, C. Bertolotto, 2012, The Journal of Biological Chemistry.

Cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)/NF-κB signaling pathway

V. Prod’homme, M. Deckert, S. Tartare-Deckert, 2019, Oncogene.

Disrupting USP39 deubiquitinase function impairs the survival and migration of multiple myeloma cells through ZEB1 degradation

F. Luciano, P. Brest, M. Dufies, 2024, bioRxiv.